Steris | STE - Selling And Administration Expenses

Stock Price
221.80
Daily Change
-1.72 -0.77%
Monthly
-0.71%
Yearly
-1.42%
Q2 Forecast
220.82

Steris reported $352.3M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
3M USD 744M 221M Mar/2026
Accuray USD 127.32M 500.16M Sep/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
CONMED USD 166.76M 26.42M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Ecolab USD 1.06B 18.2M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Fortive USD 417.4M 10.2M Dec/2025
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 318.48M 4.88M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Masimo USD 128M 11.6M Dec/2025
Olympus JPY 125.65B 5.75B Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Owens Minor USD 258.98M 7.5M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025